FDA approves new treatment for inhalation anthrax - FDA Press Releases

On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.

from Food and Drug Administration--Press Releases http://ift.tt/22yHMFf
via IFTTT